Significance of histologic type of primary lesion and metastatic lymph nodes as a prognostic factor in stage III colon cancer

Diseases of the Colon and Rectum

Volumn 49, Issue 7, 2006, Pages 982-992

  Mori, Takeo ^a   Hirota, Teruyuki ^b   Ohashi, Yasuo ^c   Kodaira, Susumu ^d  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TEIKYO UNIVERSITY   (Japan)

Author keywords

1 Hexylcarbamoyl 5 fluorouracil; Adjuvant chemotherapy; Colon cancer; Histoprognosis

Indexed keywords

CARMOFUR; MITOMYCIN C;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADENOCARCINOMA; ALKYLATING AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MITOMYCIN; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33745938967     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-006-0531-4     Document Type: Article

References (24)

1. MR Moran EC James DA Rothenberger 1992 Prognostic value of positive lymph nodes in rectal cancer Dis Colon Rectum 35 579 581
2. GJ Allegra S Paik LH Colangelo 2003 Prognostic valueof thymidylate synthase, ki-67, and p53 in patients with Dukes' B and C colon cancer: A National Cancer Institute-National Surgical Adjuvant Breast Cancerand Bowel Project Collaborative Study J Clin Oncol 21 241 250
3. Y Adachi K Yasuda M Inomata 2000 Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type Cancer 89 1418 1424
4. CK Chung RJ Zaino JA Stryker 1982 Colorectal carcinoma: evaluation of histologic grade and factors influencing prognosis J Surg Oncol 21 143 148
5. FT [tmp] McDermott ES Hughes EA Pihl 1984 Influence of tumor differentiation on survival after resection for rectal cancer in a series of 1296 patients ANZ J Surg 54 53 58
6. K Takahashi T Mori M Yasuno 2000 Histologic grade of metastatic lymph node and prognosis of rectal cancer Dis Colon Rectum 43 40 46
7. Y Koyoma 1981 1-hexylcarbamoyl-5-fluorouracil (HCFU): a masked 5-fluorinated pyrimidine Cancer Treat Rev 8 147 151
8. K Ito A Yamaguchi K Miura 1996 Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU study group, the first study for colorectal cancer J Surg Oncol 62 4 9
9. K Ito A Yamaguchi K Miura 1996 Oral adjuvant chemotherapy with Carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU study group-the third study on colorectal cancer J Surg Oncol 63 107 111
10. K Sugimachi Y Maehara M Ogawa 1996 Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5- fluorouracil administration after curative resection Cancer 77 36 43
11. J Sakamoto S Kodaira C Hamada 2001 An individual patient data meta-analysis of long supported adjuvant chemotherapy with oral carmofur in patients with curatively resected colorectal cancer Oncol Rep 8 697 703
12. Japanese Society for Cancer of the Colon and Rectum 1974 Japanese Classification of Colorectal Carcinoma 5th ed. Kanehara & Co. Ltd. Tokyo, Japan
13. DR Taves 1974 Minimization: a new method of assigning patients to treatment and control groups Clin Pharmacol Ther 15 443 453
14. EL Kaplan P Meir 1958 Non-parametric estimation from incomplete observation J Am Stat Assoc 53 457 481
15. A Martling B Cedermark H Johansson 2002 The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer Br J Surg 89 1008 1013
16. S Popat R Hubner RS Houlston 2005 Systematical review of microsatellite instability and colorectal cancer prognosis J Clin Oncol 23 609 618
17. M Tanaka Y Hashiguchi H Ueno 2003 Tumor budding at the invasive margin can predict patients athigh risk of recurrence after curative surgery for stage II, T3 colon cancer Dis Colon Rectum 46 1054 1059
18. T Okuyama M Oya H Ishikawa 2003 Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma J Surg Oncol 83 42 47
19. K Komuta S Okudaira M Haraguchi J Furui T Kanematsu 2001 Identification of extracapsular invasion of the metastatic lymph nodes as a useful prognostic sign in patients with resectable colorectal cancer Dis Colon Rectum 44 1838 1844
20. E Mamounas S Wieand N Wolmark 1999 Comparative efficacy of adjuvant chemotherapy in patients with Dukes' C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol 17 1349 1355
21. DG Haller PJ Catalano JS Macdonald 1998 Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: five-year final reportof INT-0089 Proc Am Soc Clin Oncol 17 256
22. ML Rothenberg AM Oza RH Bigelow 2003 Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial J Clin Oncol 21 2059 2069
23. LB Saltz JV Cox C Klanke 2000 Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer N Engl J Med 343 905 914
24. T Andre C Boni L Mounedji-Boudiaf 2004 Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2343 2351